SSY Group Limited (HKG:2005)

Market Cap	8.61B
Revenue (ttm)	4.58B
Net Income (ttm)	658.92M
Shares Out	2.90B
EPS (ttm)	0.22
PE Ratio	13.31
Forward PE	12.04
Dividend	0.15 (4.88%)
Ex-Dividend Date	Sep 11, 2025

Volume	2,636,000
Average Volume	4,779,269
Open	2.980
Previous Close	2.970
Day's Range	2.940 - 2.980
52-Week Range	2.580 - 3.500
Beta	0.54
RSI	46.54
Earnings Date	Mar 26, 2026

About SSY Group

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceuti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 5,700
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2024, SSY Group's revenue was 5.77 billion, a decrease of -10.67% compared to the previous year's 6.46 billion. Earnings were 1.06 billion, a decrease of -19.53%.